Loxo Oncology, Inc.
Loxo Oncology, Inc. (LOXO) is a publicly traded company in the Unknown sector. Across all available filings, 35 corporate insiders have executed 631 transactions totaling $636.7M, demonstrating a bearish sentiment with -$445.0M in net insider flow. The most recent transaction on Feb 15, 2019 involved a transaction of 30,000 shares valued at $7.0M.
LOXO Insider Activity Summary
Who Is Buying LOXO Stock?
No significant insider buying has been recorded for LOXO in the recent period.
Who Is Selling LOXO Stock?
No significant insider selling has been recorded for LOXO in the recent period.
Is Loxo Oncology, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for LOXO is bearish with an Insider Alignment Score of 15/100 and a net flow of -$445.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
LOXO Frequently Asked Questions
Understanding LOXO Insider Activity
Insider trading at Loxo Oncology, Inc. (LOXO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 35 insiders are actively trading LOXO stock, having executed 631 transactions in the past 90 days. The most active insider is Steve Elms (Executive), who has made 4 transactions totaling $522.0M.
Related Tools
Track Loxo Oncology, Inc. Insider Activity
Get notified when executives and directors at LOXO file new Form 4 transactions